14, Rue Kleberg
Geneva, CH-1201
Switzerland
Toll free: 1-866-505-2895
Phone: (416) 489-0092
E-Mail: info@anavex.comThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Stock symbol: AVXL.OB
Description:
Anavex Life Sciences Corp. (www.anavex.com) is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company’s proprietary SIGMACEPTOR(TM) Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances. Selected drug candidates demonstrate high, non-exclusive affinity for sigma receptors, which are involved in the modulation of multiple cellular biochemical signaling pathways.